PMC:7534795 / 57460-57743 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T406","span":{"begin":228,"end":236},"obj":"Disease"}],"attributes":[{"id":"A406","pred":"mondo_id","subj":"T406","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ate the inflammatory response (Bistrian, 2020). In agreement with this idea, Torrinhas et al. suggested the immune modulatory properties of n-3 PUFAs will provide important and beneficial effects to improve clinical outcomes of COVID-19 particularly in hospitalized high-risk populat"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T46084","span":{"begin":144,"end":149},"obj":"Chemical"}],"attributes":[{"id":"A60987","pred":"chebi_id","subj":"T46084","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"}],"text":"ate the inflammatory response (Bistrian, 2020). In agreement with this idea, Torrinhas et al. suggested the immune modulatory properties of n-3 PUFAs will provide important and beneficial effects to improve clinical outcomes of COVID-19 particularly in hospitalized high-risk populat"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T105","span":{"begin":8,"end":29},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"ate the inflammatory response (Bistrian, 2020). In agreement with this idea, Torrinhas et al. suggested the immune modulatory properties of n-3 PUFAs will provide important and beneficial effects to improve clinical outcomes of COVID-19 particularly in hospitalized high-risk populat"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1739","span":{"begin":228,"end":236},"obj":"Disease"}],"attributes":[{"id":"A1739","pred":"tao:has_database_id","subj":"1739","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ate the inflammatory response (Bistrian, 2020). In agreement with this idea, Torrinhas et al. suggested the immune modulatory properties of n-3 PUFAs will provide important and beneficial effects to improve clinical outcomes of COVID-19 particularly in hospitalized high-risk populat"}